β-Catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

Cited by papers we hold 14

• The Importance of Breast Adipose Tissue in Breast Cancer · 2020
  No notice
• Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model · 2020
  No notice
• Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments · 2020
  No notice
• Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics · 2019
  No notice
• Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation · 2017
  Corrected
• Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway · 2015
  No notice
• Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells · 2015
  No notice
• β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells · 2015
  No notice
• GSK-3 as potential target for therapeutic intervention in cancer · 2014
  No notice
• Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells · 2013
  No notice
• The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development · 2009
  No notice
• Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer · 2008
  Corrected
• The Wnt pathway regulator DKK1 is preferentially expressed in hormone-resistant breast tumours and in some common cancer types · 2007
  No notice
• Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation · 2007
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.